[1LBA-096] Construction of a novel Duchenne muscular dystrophy model cell line with CRISPR/Cas9 system

〇Takenori Shimo^1,2, Kana Hosoki¹, Satoshi Obika², Toshifumi Yokota^1,3 (1.Dept. of Med. Gene., Fac. of Med. and Dent., Univ. of Alberta, 2.Grad. Sch. of Pharm., Osaka Univ., 3.Muscular Dystrophy Canada Research Chair, Univ. of Alberta, Edmonton, AB, Canada)

CRISPR/Cas9 system, Exon skipping, Antisense oligonucleotides